TABLE 1

Modulation of (−)DOB-induced Fos-like immunoreactivity in medial prefrontal cortex and somatosensory cortex

Animals (n = 6-8 per group) were given LY341495 (3.0 mg/kg i.p.) or saline 10 min before BINA (65 mg/kg i.p.) or vehicle 40 min before (−)DOB (1.0 mg/kg s.c.) or saline. Shown is the number of Fos-LI-positive cells in the region of the mPFC or SSC analyzed. BINA attenuated the (−)DOB-induced Fos expression in the mPFC but not the SSC, an effect reversed by the mGlu2/3 receptor antagonist LY341495. BINA did not significantly alter Fos expression alone. LY341495 significantly increased saline-induced but not (−)DOB-induced Fos expression.

Drug Treatments, mg/kg Number of Fos-LI-Positive Cells
mPFC SSC
Saline-vehicle-saline 29.1 ± 4.2 0.13 ± 0.085
LY341495-vehicle-saline 50.3 ± 7.2* 0.57 ± 0.25
Saline-BINA-saline 30.4 ± 4.0 1.2 ± 0.38
Saline-vehicle-DOB 51.4 ± 4.1* 37.0 ± 5.4*
Saline-BINA-DOB 30.4 ± 4.0 46.3 ± 10.5*
LY341495-vehicle-DOB 65.0 ± 7.4* 52.4 ± 12.2*
LY341495-BINA-DOB 58.4 ± 6.3* 67.8 ± 14.9*
  • * Significant difference from saline-vehicle-saline treatment.

  • Significant difference from saline-BINA-DOB treatment.